March 18, 2020 / 4:57 PM / 21 days ago

BRIEF-Catalyst Pharmaceuticals CEO, On Impact Of Covid-19, Says Implementing Virtual Approach To Guarantee Patients Continual Access To Firdapse

March 18 (Reuters) - Catalyst Pharmaceuticals Inc:

* CATALYST PHARMACEUTICALS CEO, ON IMPACT OF COVID-19, SAYS IMPLEMENTING VIRTUAL APPROACH TO GUARANTEE PATIENTS CONTINUAL ACCESS TO FIRDAPSE

* CATALYST PHARMACEUTICALS CEO- IN PHASE 3 MUSK-MG CLINICAL STUDY, REMAINING WORK INVOLVES MOSTLY VIRTUAL WORK & EXPECT TO REPORT TOP-LINE RESULTS IN Q2 Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below